ArticleJournal of family medicine and primary care2025
Is nonalcoholic fatty liver disease associated with metabolic syndrome? An experience from a medical college of West Bengal, India.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Nonalcoholic fatty liver disease (NAFLD), a wide spectrum of liver disease ranged from mild steatosis to advance fibrosis, cirrhosis, liver failure and hepato-cellular carcinoma, showed rising trend globally. Prevalent evidences support coexistence between NAFDL and metabolic syndrome. Aims: The present study aims to demonstrate the sociodemographic and clinical profile of nonalcoholic fatty liver diseases and its association with metabolic syndrome if any. Materials and Methods: The present cross-sectional study was conducted among the 120 patients diagnosed as NAFLD by ultrasonography as well as similar numbers of matching controls in a tertiary care teaching hospital of eastern part of India. Relevant anthropometric measurements, laboratory investigations and imaging techniques were performed. Metabolic syndrome was classified by the 'International Diabetes Federation, 2005' criteria. Pearson's chi-square test used for measures of association, and Results: The overall prevalence of metabolic syndrome among the NAFLD study population was 64.2%. Significant positive association found with several cardiometabolic components such as increased body mass index, central obesity, hypertension, fasting blood sugar, dyslipidaemia and NAFLD. Conclusion: The prevalence of metabolic syndrome among NAFLD patients was found quite high and significant positive association found between metabolic syndrome and its components and NAFLD. Early detection of NAFLD might play a vital role in preventive cardiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.